Company news

OKYO Pharma Limited news in 2025

OKYO Pharma Limited's news releases, calls and decks from 2025, newest first.

View company

OKYO Pharma to Ring the Opening Bell at Nasdaq

December 19, 2025

OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain

December 11, 2025

OKYO Pharma to Present at OIS XV in San Diego

November 18, 2025

OKYO Pharma to Present at BIO-Europe 2025 in Vienna

October 29, 2025

OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain

September 22, 2025

OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain

July 17, 2025

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

July 16, 2025

OKYO Pharma to Present at the Bio International Convention

June 11, 2025

OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit

May 19, 2025

Decks in 2025